Entry Point Capital, LLC Harrow Health, Inc. Call Options Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HROW
# of Institutions
127Shares Held
19.8MCall Options Held
700KPut Options Held
564K-
Opaleye Management Inc. Boston, MA3.99MShares$177 Million21.35% of portfolio
-
Private Capital Management, LLC Naples, FL2.71MShares$121 Million7.1% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$95.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$81.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA719KShares$31.9 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.2B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...